Paper - WANFANG MED ONLINE

You Position: Home > Paper

Current knowledge and management recommendation of atrial fibrillation——2012

( views:47, downloads:2920 )

Author:: No author available

Journal Title:: Chinese Journal of Cardiac Arrhythmias

Issue:: 4

DOI:: 10.3760/cma.j.issn.1007-6638.2012.04.002

Key Word:: No keyword available

Abstract：前言自2010年中华医学会心电生理和起搏分会( China Society of Pacing and Electrophysiology,CSPE)制订并发表《心房颤动:目前的认识和治疗建议——2010》以来,欧洲心脏病学会(European Society of Cardiology,ESC),美国心脏协会( American Heart Association,AHA),加拿大心血管病学会(Canadian Cardiovascular Society,CCS),美国心律学会(Heart Rhythm Society,HRS)与欧洲心律学会(European Heart Rhythm Society,EHRS)、欧洲心血管学会(European Cardiovascular Society,ECAS)联合等又陆续发表了新的相关指南或建议,均提供了大量新的学术信息与专家共识;与此同时,国内学者在该领域亦有新的研究成果与临床经验问世.为此,CSPE为及时吸收国内外最新学术成果以丰富2010年版建议,故对2010年建议予以修订.

Reference

[1]马坚,唐恺,麻付胜,等.环肺静脉电隔离术后房性快速心律失常的机制和再消融治疗[J].2007,(2).
[2]周自强,胡大一,陈捷,等.中国心房颤动现状的流行病学研究[J].2004,(7).
[3]吴钢,江洪,黄从新,等.环肺静脉射频消融术治疗心房颤动复发的预测因子探讨[J].2007,(4).
[4]黄从新,马长生,张澍,等.经导管消融心房颤动中国专家共识[J].2008,(4).
[5]杨延宗,黄从新,高连君,等.阵发性心房颤动患者心脏大静脉肌袖电活动特征的临床研究[J].2005,(1).
[6]谢双伦,黄从新,江洪,等.兔上下腔静脉中的心肌细胞组织结构研究[J].2003,(4).
[7]黄鹤,江洪,杨波,等.慢性心房颤动消融术后房性心动过速的机制和消融治疗[J].2008,(4).
[8]中华医学会心血管病分会.中国部分地区心房颤动住院病例回顾性调查[J].2003,(12).
[9]杨延宗,黄从新,刘少稳,等.阵发性心房颤动患者肺静脉与心房电连接特征的临床研究[J].2003,(2).
[10]马长生,孟旭,诸学时.房颤治疗：外科射频消融术与内科导管射频消融术孰优?[J].2006,(11).
[11]牛凡,黄从新,江洪,等.犬Bachmann束与心房颤动的关系及其关键消融部位[J].2005,(1).
[12]龙德勇,刘兴鹏,马长生,等.心房颤动射频消融术中应用丙泊酚深度镇静的临床观察[J].2006,(5).
[13]谢强,黄从新,李卫华,等.Marshall韧带的形态学研究[J].2006,(3).
[14]张建成,黄从新,邓玉莲,等.心房颤动患者离子重构的分子基础[J].2002,(2).
[15]吴钢,黄从新,江洪,等.经导管消融治疗心房颤动的复发原因分析[J].2008,(6).
[16]王晞,黄从新,江洪,等.兔肺静脉心肌袖组织学特性研究[J].2003,(4).
[17]马长生,黄从新,刘兴鹏,等.141例阵发性心房颤动经导管消融治疗的并发症分析[J].2003,(2).
[18]马长生,刘兴鹏,刘旭,等.经球囊超声消融肺静脉治疗阵发性心房颤动的临床评价[J].2003,(7).
[19]马长生,周玉杰,马煜,等.中国人非瓣膜病心房颤动患者脑卒中发生率及影响因素的回顾性前瞻研究（摘要）[J].1999,(Z1).
[20]吴钢,黄从新,江洪,等.肺静脉内不同温度射频消融对血液动力学的影响[J].2001,(2).
[21]Liu Jie,HUANG Cong-xin,BAO Ming-wei,etc.Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro[J].2005,(14).
[22]王晞,黄从新,王腾.兔肺静脉肌袖心肌细胞动作电位和钾、钙离子流特性的研究[J].2002,(4).
[23]喻荣辉,马长生,董建增,等.电解剖标测和磁共振影像融合技术指导导管消融心房颤动的有效性研究[J].2007,(11).
[24]伍伟锋,黄从新,刘唐威,等.心房颤动患者心房组织血管紧张素Ⅱ受体表达的研究[J].2002,(4).
[25]杨延宗,黄从新,高连君,等.阵发性心房颤动大静脉电隔离后肌袖内自发电活动的特点[J].2004,(3).
[26]黄从新,刘育,张澍,等.环肺静脉消融治疗心房颤动的有效性和安全性：一项多中心临床注册研究[J].2008,(4).
[27]黄从新,张澍,马长生,等.心房颤动：目前的认识和治疗建议-2010[J].2010,(5).
[28]崔永强,孟旭,李岩,等.干式双极射频消融手术治疗器质性心房颤动[J].2010,(6).
[29]胡大一,孙艺红,周自强,等.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].2003,(3).
[30]黄从新,江洪,吴钢,等.肺静脉内射频消融温度与肺静脉狭窄的关系研究[J].2001,(3).
[31]李莉,汪曾炜,徐志云,等.慢性房颤伴二尖瓣病的迷宫手术24例八年随访[J].2005,(2).
[32]黄鹤,杨波,江洪,等.心房颤动环肺静脉隔离术后复发左房房性心动过速的特点及消融治疗[J].2007,(5).
[33]黄从新,张澍,马长生,等.中国经导管消融治疗心房颤动注册研究[J].2006,(6).
[34]伍伟锋,黄从新,刘唐威,等.心房颤动患者心房组织连接蛋白40和连接蛋白43基因转录表达的研究[J].2002,(4).
[35]江洪,黄从新,唐其柱,等.肺静脉异常电活动引起持续性心房颤动的电生理特点和消融治疗[J].2004,(3).
[36]王辉山,汪曾炜,李新民,等.141例心脏手术同期施行双极射频迷宫手术治疗心房颤动[J].2009,(6).
[37]Starck C,Roser D,Paula J,etc.Results of a modified left atrial maze procedure as a combined procedure.[J].2003,51(3).
[38]Granger CB,Alexander JH,McMurray JJ,etc.Apixaban versus warfarin in patients with atrial fibrillation.[J].2011,365(11).
[39]Rostock T,Sacher F,Clementy J,etc.Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.[J].2005,16(11).
[40]Calkins H,Vasamreddy CR,Jayam VK,etc.Predictors of Recurrence Following Catheter Ablation of Atrial Fibrillation Using an Irrigated-Tip Ablation Catheter.[J].2004,15(6).
[41]Kawano Y,Sasaki A,Yasuda M,etc.Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation.[J].2005,69(1).
[42]Davidoff R,Apperson-Hansen C,Asinger RW,etc.Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.[J].2001,344(19).
[43]Fox KA,Piccini JP,Mahaffey KW,etc.Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.[J].2011,32(19).
[44]Otomo K,Kuck KH,Schmidt B,etc.Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound.[J].2010,3(3).
[45]V Tuseth,K Dickstein,H J Jaatun.Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment[J].2005,91(7).
[46]Varma J,Dawn B,Stoddard MF,etc.Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters.[J].2005,18(3).
[47]Levy S.Classification system of atrial fibrillation.[J].2000,15(1).
[48]Drogemuller A,Vater M,Bergmeier C,etc.Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.[J].2002,39(9).
[49]Olshansky B,Guo H.Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.[J].2005,3(4).
[50]Eckardt L,Wasmer K.Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines.[J].2011,13(10).
[51]Leheuzey JY,de Vos CB,Pisters R,etc.Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.[J].2008,29(5).
[52]Zado ES,Dixit S,Callans DJ,etc.Incidence and predictors of very late recurrence of atrial fibrillation after ablation.[J].2007,18(1).
[53]Iesaka Y,Kalman J,Cappato R,etc.Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.[J].2010,3(1).
[54]Lincoff AM,Hiatt WR,Harrington RA.Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.[J].2008,117(22).
[55]Crijns H,Weintraub W,Camm J,etc.The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.[J].2010,105(5).
[56]Zhang XQ,Chen SH,Yoo S,etc.Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death[J].2008,135(6).
[57].Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions[J].1992.
[58]Osterday R,Merrill W,Schneeberger EW,etc.Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation.[J].2005,130(3).
[59]Daly RC,Orszulak TA,Dearani JA,etc.Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience.[J].2000,12(1).
[60]Camillo CJ,Sundt TM 3rd,Cox JL,etc.The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.[J].2003,126(6).
[61]Diener HC,Parkhomenko A,O'Donnell M,etc.Apixaban in patients with atrial fibrillation.[J].2011,364(9).
[62]Goette A,Ernst S,Prendergast B,etc.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).[J].2010,31(19).
[63]Limbourg T,Goette A,Meinertz T,etc.The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.[J].2009,11(4).
[64]Sala S,Paglino G,Greiss I,etc.A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.[J].2006,48(11).
[65]Kim KC,Kim YJ,Cho KR,etc.Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience.[J].2007,31(2).
[66]Frison L,Lane DA,Halperin JL,etc.Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.[J].2010,41(12).
[67]Lakkireddy D,Fahmy TS,Cummings JE,etc.Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up.[J].2006,48(12).
[68]Yusuf S,Connolly SJ,Ezekowitz MD.Dabigatran versus warfarin in patients with atrial fibrillation.[J].2009,361(12).
[69]Nademanee K,McKenzie J,Kosar E,etc.A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.[J].2004,43(11).
[70]Camm AJ,Skehan JD,Toff WD.Single-chamber versus dual-chamber pacing for high-grade atrioventricular block.[J].2005,353(2).
[71]Powell A,Davis M,Shah C,etc.The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).[J].2003,41(10).
[72]Ezekowitz MD,Sharma SC,Singh SN,etc.Amiodarone versus sotalol for atrial fibrillation.[J].2005,352(18).
[73]Sucu M,Davutoglu V,Ozer O.Electrical cardioversion.[J].2009,29(3).
[74]Hua TA,Kjeldsen SE,Julius S,etc.Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.[J].2008,26(3).
[75]Clementy J,Rotter M,Sacher F,etc.Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation.[J].2005,16(10).
[76]David J. Callans.Apples and Oranges Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation[J].2008,118(24).
[77]Olesen JB,Lip GY,Lindhardsen J,etc.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.[J].2011,106(4).
[78]Yusuf S,Healey JS,Connolly SJ,etc.Irbesartan in patients with atrial fibrillation.[J].2011,364(10).
[79]Rothbart RM,McBride R,Hart RG,etc.Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.[J].1999,30(6).
[80]Fujiki A,Origasa H,Inoue H.Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination.[J].2009,137(2).
[81]Wilber DJ,Pappone C,Neuzil.Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.[J].2010,303(4).
[82]Rostock T,Sacher F,Clementy J,etc.Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.[J].2005,16(11).
[83]Khan MN,Jais P,Cummings J,etc.Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.[J].2008,359(17).
[84]Wolf Philip A..Atrial Fibrillation: A Major Contributor to Stroke in the Elderly[J].1987.
[85]Belhassen B.A 1 per 1,000 mortality rate after catheter ablation of atrial fibrillation: an acceptable risk?[J].2009,53(19).
[86]Friberg J,Gadsboll N.Intracardiac Low-Energy versus Transthoracic High-Energy Direct-Current Cardioversion of Atrial Fibrillation: A Randomised Comparison.[J].2003,99(2).
[87]Rostock T,Hsu LF,Sacher F,etc.Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome.[J].2007,28(15).
[88]Lin H.-J.,Wolf P. A.,Kelly-Hayes M.,etc.Stroke Severity in Atrial Fibrillation: The Framingham Study[J].1996.
[89]Macle L,Verma A,Cox J,etc.Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.[J].2011,27(1).
[90]Cokkinos DV,Maggioni AP,Nieuwlaat R,etc.Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.[J].2008,10(4).
[91].Effects of Enalapril on Mortality in Severe Congestive Heart Failure[J].1987.
[92]Goya M,Muller KM,Ouyang F,etc.Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease.[J].2003,14(4).
[93]Watson T,Shantsila E,Lip GY.Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.[J].2009,373(9658).
[94]Yamashita T,Aizawa T,Sagara K,etc.Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.[J].2007,71(6).
[95]Decker WW,Meloy TD,Raghavan AV.Management of atrial fibrillation in the emergency department.[J].2005,23(4).
[96]Takahashi A,Haissaguerre M,Jais P,etc.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.[J].1998,339(10).
[97]Allessie MA,Boyden PA,Camm AJ,etc.Pathophysiology and prevention of atrial fibrillation.[J].2001,103(5).
[98]Miller V. T.,Rothrock J. F.,Pearce L. A.,etc.Ischemic stroke in patients with atrial fibrillation: Effect of aspirin according to stroke mechanism[J].1993.
[99]R G, Hart,J L, Halperin.Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention.[J].1999,131(9).
[100]G Q, Villani,M F, Piepoli,C, Terracciano,etc.Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study.[J].2000,140(3).
[101]Benjamin, Emelia J.,Levy, Daniel.Independent risk factors for atrial fibrillation in a population-based cohort.[J].1994,271(11).
[102]A M, Gillinov,G, Pettersson,T W, Rice.Esophageal injury during radiofrequency ablation for atrial fibrillation.[J].2001,122(6).
[103]D, SCHERF,A I, SCHAFFER,S, BLUMENFELD.Mechanism of flutter and fibrillation.[J].1953,91(3).
[104]Scavee C,Sacher F,Clementy J,etc.Catheter ablation for atrial fibrillation in congestive heart failure.[J].2004,351(23).
[105]Deedwania,PC,Singh,BN,Ellenbogen,K,etc.Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Depa[J].1998,98(23).
[106]M, Grogan,H C, Smith,B J, Gersh,etc.Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.[J].1992,69(19).
[107]Carlos A C, Abreu Filho,Luiz A F, Lisboa,Luís A O, Dallan,etc.Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease.[J].2005,112(9 Suppl).
[108]S. Lévy,G. Breithardt,R.W.F. Campbell,etc.Atrial fibrillation: current knowledge and recommendations for management[J].1998,19(9).
[109]Robert G, Hart,Lesly A, Pearce,Maria I, Aguilar.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.[J].2007,146(12).
[110]Peter J, Zimetbaum.Dronedarone for atrial fibrillation--an odyssey.[J].2009,360(18).
[111]Jackson K,Lopes RD,Kong MH,etc.Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.[J].2009,2(6).
[112]Douglas L Packer,D Wyn Davies,A John Camm,etc.2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.[J].2012,14(4).
[113]J L, Cox,T E, Canavan,R B, Schuessler,etc.The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation.[J].1991,101.
[114]E V, Platia,E L, Michelson,J K, Porterfield,etc.Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.[J].1989,63(13).
[115]A, Cameron,M J, Schwartz,R A, Kronmal,etc.Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry).[J].1988,61(10).
[116]E N, Prystowsky,D W, Benson,V, Fuster,etc.Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.[J].1996,93.
[117]D, Fatkin,R P, Kelly,M P, Feneley.Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo.[J].1994,23(4).
[118]J S, Shinbane,M A, Wood,D N, Jensen,etc.Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies.[J].1997,29(4).
[119]Sehra R,Calkins H,Pelkey W,etc.Transvenous catheter cryoablation for treatment of atrial fibrillation: results of a feasibility study.[J].2005,28(Suppl.1).
[120]R B, Schuessler,T M, Grayson,B I, Bromberg,etc.Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium.[J].1992,71.
[121]A S, Volgman,P A, Carberry,B, Stambler,etc.Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.[J].1998,31(6).
[122]Ng TP,Yap KB,Ong HY.Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study.[J].2008,41(2).
[123]Dong J,Dickfeld T,Dalal D,etc.Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation.[J].2006,17(5).
[124]Hernandez,A.V.,Uchino,K..Dabigatran association with higher risk of acute coronary events: Meta-analysis of noninferiority randomized controlled trials[J].2012,172(5).
[125]Koullick M,Hettrick D,Nsah E,etc.Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.[J].2007,357(10).
[126]Schmidt B,Tilz R,Ernst S,etc.Inducibility of atrial tachyarrhythmias after circumferential pulmonary vein isolation in patients with paroxysmal atrial fibrillation: clinical predictor and outcome during follow-up.[J].2008,10(8).
[127]Gillis AM,Verma A,Talajic M,etc.Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.[J].2011,27(1).
[128]Cox JL,Schuessler RB,Boineau JP.The development of the Maze procedure for the treatment of atrial fibrillation.[J].2000,12(1).
[129]Kalusche D,Peng JT,Haissaguerre M,etc.Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers.[J].2000,11(1).
[130]Chen SA,Cappato R,Calkins H.Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation.[J].2009,53(19).
[131]Orav EJ,Goldman L,Lamas GA,etc.Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.[J].2002,346(24).
[132]Armstrong PW,Granger CB,Al-Khatib SM,etc.Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.[J].2008,94(7).
[133]Matsuo S,Lellouche N,Wright M.Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation.[J].2009,54(9).
[134]van Staa TP,Clemens A,Setakis E,etc.Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.[J].2011,106(5).
[135]XWang,XLiu,HShi,etc.Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases[J].2009,95(21).
[136]Baruch L,Labovitz A,Gage BF,etc.Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?[J].2007,38(9).
[137]Arantes L,Sacher F,Clementy J,etc.Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint.[J].2009,30(9).
[138]Dubuc M,Carrier M,Leung TK,etc.Surgical radiofrequency ablation induces coronary endothelial dysfunction in porcine coronary arteries.[J].2003,23(3).
[139]Van Gelder IC,Hagens VE,Bosker HA,etc.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.[J].2002,347(23).
[140]Anter E,Jessup M,Callans DJ.Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.[J].2009,119(18).
[141]Tsioufis C,Syrseloudis D,Hatziyianni.Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects.[J].2010,23(2).
[142]Tekumit H,Tataroglu C,Polat A,etc.Midterm results of left atrial bipolar radiofrequency ablation combined with a mitral valve procedure in persistent atrial fibrillation.[J].2010,21(3).
[143]La Rocca V,Tondo C,Mantica M,etc.Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience.[J].2010,12(2).
[144]de Vos CB,Crijns HJ,Lip GY,etc.A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.[J].2010,138(5).
[145]Pfeffer M,Hart R,Hohnloser S,etc.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.[J].2006,367(9526).
[146]Deneke T,Hutten BA,Lemke B,etc.Surgical treatment of atrial fibrillation; a systematic review.[J].2005,27(2).
[147]Ogawa S,Sadanaga M,Sadanaga T.Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.[J].2010,55(20).
[148]Marini C,De Santis F,Sacco S,etc.Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study.[J].2005,36(6).
[149]McCarthy PM,Cosgrove D-3rd,Castle L,etc.The Cox-Maze procedure: the Cleveland Clinic experience.[J].2000,12(1).
[150]Knecht S,Clementy J,Jais P,etc.Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation.[J].2008,29(19).
[151]Gage BF,Shannon W,Radford MJ,etc.Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.[J].2001,285(22).
[152]Dalal D,Henrikson CA,Calkins H,etc.Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation.[J].2006,17(2).
[153]Khoo CW,Lip GY.Acute management of atrial fibrillation.[J].2009,135(3).
[154]Chew D,Lau DH,Huynh LT.Prognostic impact of types of atrial fibrillation in acute coronary syndromes.[J].2009,104(10).
[155]Anderson RH,Cabrera JA,Ho SY,etc.Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation.[J].1999,10(11).
[156]Gerk U,Park JW,Vrsansky M,etc.Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.[J].2009,21(9).
[157].Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version.[J].2010,74(11).
[158]Frison L,Lane DA,Halperin JL,etc.Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drug[J].2011,57(2).
[159]Pierre B,Fauchier L,de-Labriolle A,etc.Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials.[J].2008,51(8).
[160]Van Gelder IC,Groenveld HF,Crijns HJ,etc.Lenient versus strict rate control in patients with atrial fibrillation.[J].2010,362(15).
[161]Zingman LV,Heublein DM,Burnett-JC Jr,etc.Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.[J].2008,359(2).
[162]Tabatabaie MB,Javadpour H,Hosseini S,etc.Cryoablation for surgical treatment of chronic atrial fibrillation combined with mitral valve surgery: a clinical observation.[J].2008,33(6).
[163]Pogue J,Connolly SJ,Hart RG.Effect of clopidogrel added to aspirin in patients with atrial fibrillation.[J].2009,360(20).
[164]Latini R,Di-Pasquale G,Disertori M,etc.Valsartan for prevention of recurrent atrial fibrillation.[J].2009,360(16).
[165]Baggio G,Bilato C,Corti MC.Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study).[J].2009,104(8).
[166]Newman DM,Connolly SJ,Kerr CR,etc.Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.[J].2000,342(19).
[167]Raanani E,Yau TM,Albage A,etc.The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study.[J].2001,19(4).
[168]DONGPING FANG,XINGPENG LIU,HERCULES E. MAVRAKIS,etc.Achievement of Pulmonary Vein Isolation in Patients Undergoing Circumferential Pulmonary Vein Ablation: A Randomized Comparison Between Two Different Isolation Approaches[J].2006,17(12).
[169]Kaiser SP,Melby SJ,Damiano RJ Jr,etc.Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output.[J].2006,132(2).
[170]van Latum J.C.,Koudstaal P.J.,Venables G.S.,etc.Predictors of Major Vascular Events in Patients With a Transient Ischemic Attack or Minor Ischemic Stroke and With Nonrheumatic Atrial Fibrillation[J].1995.
[171]Nakagawa H,Schmidt B,Ernst S,etc.Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation.[J].2007,18(2).
[172]Gillis AM,Skanes AC.Canadian Cardiovascular Society atrial fibrillation guidelines 2010: implementing GRADE and achieving consensus.[J].2011,27(1).
[173]Handke M,Olschewski M,Bode C,etc.Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a transesophageal echocardiographic study in 500 patients with cerebr[J].2005,18(12).
[174]Petersen P..Thromboembolic complications in atrial fibrillation[J].1990.
[175]Ruskin J,Reddy V,Keane D.Emerging concepts on catheter ablation of atrial fibrillation from the tenth annual Boston Atrial Fibrillation Symposium.[J].2005,16(9).
[176]Glotzer TV,Daoud EG,Wyse DG,etc.The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.[J].2009,2(5).
[177]Pedersen OD,Bagger H,Kober L,etc.Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.[J].2001,104(3).
[178]Jorgensen H. S.,Nakayama H.,Reith J.,etc.Acute Stroke With Atrial Fibrillation: The Copenhagen Stroke Study[J].1996.
[179]Hoffmann DA,Roques X,Deville C,etc.Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial.[J].2005,130(3).
[180]Yusuf S,Dyal L,Dagenais G,etc.Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.[J].2008,372(9644).
[181]Rosanio S,Gulletta S,Pappone C,etc.Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation.[J].2001,104(21).
[182]Wolf P. A.,Abbott R. D.,Kannel W. B..Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J].1991.
[183]H, Oral,J J, Souza,G F, Michaud,etc.Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.[J].1999,340(24).
[184]Legrand M,Mateo J,Aribaud A,etc.The use of dabigatran in elderly patients.[J].2011,171(14).
[185]J E, Lindeboom,J H, Kingma,H J, Crijns,etc.Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.[J].2000,85(8).
[186]Brugada, Ramon,Tapscott, Terry,Czernuszewicz, Grazyna Z.,etc.Identification of a Genetic Locus for Familial Atrial Fibrillation.[J].1997,336(13).
[187]M, Ha?ssaguerre,D C, Shah,P, Ja?s,etc.Electrophysiological breakthroughs from the left atrium to the pulmonary veins.[J].2000,102(20).
[188]Lip GY,Nieuwlaat R,Pisters.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.[J].2010,137(2).
[189]Stanley, Nattel.New ideas about atrial fibrillation 50 years on.[J].2002,415(6868).
[190].Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk...[J].1996,348(9028).
[191]Sophie, Cardin,Danshi, Li,Nathalie, Thorin-Trescases,etc.Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.[J].2003,60(2).
[192]Holmes,D.R.,Reddy,V.Y.,Turi,Z.G.,etc.Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial[J].2009,374(9689).
[193]Benjamin J, Scherlag,Hiroshi, Nakagawa,Warren M, Jackman,etc.Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation.[J].2005,13 Suppl 1.
[194]Dries,DL,ol.com,Exner,DV,etc.Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ve[J].1998,32(3).
[195]Frederic, Sacher,Pierre, Jais,Kent, Stephenson,etc.Phrenic nerve injury after catheter ablation of atrial fibrillation.[J].2007,7(1).
[196]Connolly SJ,Crijns HJ,Page RL,etc.Effect of dronedarone on cardiovascular events in atrial fibrillation.[J].2009,360(7).
[197]A W, Moulton,D E, Singer,J S, Haas.Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study.[J].1991,91(2).
[198]W B, Kannel,R D, Abbott,D D, Savage,etc.Epidemiologic features of chronic atrial fibrillation: the Framingham study.[J].1982,306.
[199]Valentin, Fuster,Lars E, Rydén,Davis S, Cannom,etc.2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidel[J].2011,57(11).
[200]Winter Y,Wolfram C,Schaeg M.Evaluation of costs and outcome in cardioembolic stroke or TIA.[J].2009,256(6).
[201]P, Coumel,P, Attuel,J, Lavallée,etc.[The atrial arrhythmia syndrome of vagal origin].[J].1978,71(6).
[202]H R, Middlekauff,W G, Stevenson,L W, Stevenson.Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.[J].1991,84.
[203]D L, Packer,G H, Bardy,S J, Worley,etc.Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction.[J].1986,57(8).
[204]Verma A,Marrouche NF,Saliba W,etc.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.[J].2005,293(21).
[205]P A, Wolf,E J, Benjamin,A J, Belanger,etc.Secular trends in the prevalence of atrial fibrillation: The Framingham Study.[J].1996,131(4).
[206].Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.[J].1994,154.
[207]S, Di Benedetto.Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.[J].1997,80(4).
[208]Phillips KA,Chang Y,Go AS,etc.Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.[J].2001,285(18).
[209]S M, Sopher,A J, Camm.Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence.[J].1995,6.
[210]钱峰,傅朝蓬,李莉,等.微波消融治疗风湿性心脏病二尖瓣置换术中房颤效果[J].2009,(7).
[211]Green M,Talajic M,Kus T,etc.Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.[J].2000,342(13).
[212]Y, Shigematsu,M, Hamada,M, Mukai,etc.Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy.[J].1995,59.
[213]M C, Wijffels,C J, Kirchhof,R, Dorland,etc.Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.[J].1995,92.
[214]Hughes M,Lip GY.Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.[J].2008,99(2).
[215]Sosa E.Left Atrial-Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation.[J].2004,15(8).
[216]Shah SV,Gage BF.Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.[J].2011,123(22).
[217]Deisenhofer I,Reents T,Hessling G,etc.Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation.[J].2008,10(11).
[218]B M, Psaty,T A, Manolio,L H, Kuller,etc.Incidence of and risk factors for atrial fibrillation in older adults.[J].1997,96.
[219]J, Ausma,M, Wijffels,F, Thoné,etc.Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.[J].1997,96.
[220]Yao JF,Chen W,Jorgensen MB,etc.Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.[J].2007,50(4).
[221]P A, Wolf,J B, Mitchell,C S, Baker,etc.Impact of atrial fibrillation on mortality, stroke, and medical costs.[J].1998,158.
[222]A C, Skanes,R, Mandapati,O, Berenfeld,etc.Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart.[J].1998,98.
[223]Nattel S,Kampinga HH,Shiroshita-Takeshita A,etc.Heat shock proteins as molecular targets for intervention in atrial fibrillation.[J].2008,78(3).
[224]Jackman WM,Scherlag BJ,Edwards J,etc.Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi.[J].2007,18(1).
[225]O D, Pedersen,H, Bagger,L, Kober,etc.Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.[J].1999,100.
[226]C, Pappone,G, Oreto,F, Lamberti,etc.Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system.[J].1999,100.
[227]Millar RC,Doty DB,Arcidi JM Jr.The Maze procedure: the LDS Hospital experience.[J].2000,12(1).
[228]Gregory Y H, Lip,Kurt, Huber,Felicita, Andreotti,etc.Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by t[J].2010,31.
[229]A John, Camm,Paulus, Kirchhof,Gregory Y H, Lip,etc.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).[J].2010,12.
[230]Yang S,Di Pasquale G,Reilly PA,etc.Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.[J].2010,9(12).
[231]Sacher F,Weerasooriya R,Cauchemez B,etc.Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.[J].2008,118(24).
[232]Lana Boodhoo,Nick Freemantle,Neil Sulke John Silberbauer.The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study[J].2007,9(9).
[233]K M, Flegel,M J, Shipley,G, Rose.Risk of stroke in non-rheumatic atrial fibrillation.[J].1987,1.
[234]Koichiro Maeda,Masatoshi Koga,Yasushi Okada,etc.Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation[J].2012,312(1-2).
[235]Chen SA,Afzal R,Peters NS,etc.Dronedarone in high-risk permanent atrial fibrillation.[J].2011,365(24).
[236]G.K. Moe,J.A. Abildskov.Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge[J].1959,58(1).
[237]CLAUS SCHMITT,ECKHARD ALT,ANDREAS PLEWAN,etc.Low Energy Intracardiac Cardioversion After Failed Conventional External Cardioversion of Atrial Fibrillation[J].1996,28(4).
[238]Opie LH,Nattel S.Controversies in atrial fibrillation.[J].2006,367(9506).
[239]DiMarco JP,Rosenberg Y,Kellen JC,etc.A comparison of rate control and rhythm control in patients with atrial fibrillation.[J].2002,347(23).
[240]Robert G. Tieleman,A.T.Marcel Gosselink,Harry J.G.M. Crijns,etc.Efficacy, Safety, and Determinants of Conversion of Atrial Fibrillation and Flutter With Oral Amiodarone[J].1997,79(1).
[241]J. Andrew Armour,David A. Murphy,Bing-Xiang Yuan,etc.Gross and microscopic anatomy of the human intrinsic cardiac nervous system[J].1997,247(2).
[242]Redfield MM,Kay GN,Mianulli M,etc.Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation.[J].2000,75(8).
[243]SAMUEL LEVY,PATRICE NOVELLA,PHILIPPE RICARD,etc.Paroxysmal A trial Fibrillation:: A Need for Classification[J].1995,6(1).
[244]Anton Lishmanov,Priya Chockalingam,Annamalai Senthilkumar,etc.Tachycardia-Induced Cardiomyopathy: Evaluation and Therapeutic Options[J].2010,16(3).
[245]Kinebuchi O,Mitamura H,Shiroshita Takeshita A,etc.Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium.[J].2004,68(5).
[246]Peters NS,Davies DW,Wong T,etc.Percutaneous pulmonary vein cryoablation to treat atrial fibrillation.[J].2004,11(2).
[247]Patel MR,Mahaffey KW,Garg J,etc.Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.[J].2011,365(10).
[248]Katritsis D,Wood MA,Giazitzoglou E,etc.Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation.[J].2008,10(4).
[249]Sanders P,Monahan KH,Thomas SP,etc.Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study.[J].2006,47(12).
[250]Iafelice I,Alfieri O,Galanti A,etc.Electrophysiologic efficacy of irrigated bipolar radiofrequency in the clinical setting.[J].2010,139(5).
[251]Garcia F,Riley M,Callans DJ,etc.Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study).[J].2009,120(12).